PSCR — Proto Script Pharmaceutical Income Statement
0.000.00%
Last trade - 00:00IndustrialsHighly SpeculativeMicro Cap
- $0.01m
- $0.39m
Annual income statement for Proto Script Pharmaceutical, fiscal year end - May 31st, USD millions except per share, conversion factor applied.
2012 May 31st | 2013 May 31st | 2014 May 31st | 2015 May 31st | 2016 May 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Total Operating Expenses | 0.033 | 0.032 | 0.038 | 0.045 | 0.033 |
| Operating Profit | -0.033 | -0.032 | -0.038 | -0.045 | -0.033 |
| Net Income Before Taxes | -0.033 | -0.032 | -0.038 | -0.045 | -0.033 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.033 | -0.032 | -0.038 | -0.045 | -0.033 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.033 | -0.032 | -0.038 | -0.045 | -0.033 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.033 | -0.032 | -0.038 | -0.045 | -0.033 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.001 | -0.001 | -0.001 | -0.001 |
| Dividends per Share |